Accelerating the Implementation of Mass Spectrometry in the Clinical Lab

CMS Logo MSACL

UNITED STATES 2018

Help Us Reach Our Educational Support Goal of $40,000
Educational Travel Grants supported in part by:

Lightning Talks

Lightning Talks provide a 90-second opportunity for poster abstract presenters and vendors to provide a brief overview of their work or their offering, respectively, from the plenary podium. This activity is intended to provide the opportunity for poster presenters to highlight their work and gain experience in oral presentation from the podium, and for Exhibitors to provide a quick overview that will help audience members understand en masse the products and/or services they provide. The latter is intended to help streamline the process of the attendee-vendor interactions where the attendee is trying to understand what the Exhibitor offers and whether it is pertinent to their needs back in the lab.

Poster Lightning Talks

Tuesday : 16:30-17:00
@ Rooms 2-4 (California Ballroom)

  #3B Endogenous Digoxin and Cancer Management – Would Zika Virus be the Trigger for Glioblastomas Death Through Digoxin Synthesis?
  Estela Lima
  

  #7A Elucidation of a Naproxen Metabolite Interference in Total Bilirubin Testing on a Routine Chemistry Analyzer System Using LC-MS/MS
  Aaron Barnes
  

  #10D Tandem Mass Spectrometric Measurement of Seven Steroids in Dried Blood Spots to Diagnose Congenital Adrenal Hyperplasia
  Deema Qasrawi
  

  #12D 3D Volume Cartography of Diseased Human Lungs
  Alexey Melnik
  

  #12D 3D Volume Cartography of Diseased Human Lungs
  Alexey Melnik
  

  #14B Application of LIS Interface for Quality Control for LC-MS/MS in Therapeutic Drug Monitoring of Immunosuppressant
  Yeo-Min Yun
  

  #16D Global Natural Product Social Molecular Networking (GNPS) – an Open Resource for MS-based Metabolomics Data Sharing and Analysis
  Alexander Aksenov
  

  #28D Quantitative Proteomics-based Identification of Novel Serum Markers for First-Trimester Prediction of Gestational Diabetes Mellitus
  Martin Overgaard
  

  #34B Proteometabolomics of Myeloma Drug Resistance
  David Koomen
  

  #43B Use of a MS-based Targeted Approach for Detection of Minimal Residual Disease (MRD) in Multiple Myeloma
  Carlo Martins
  

  #43B Use of a MS-based Targeted Approach for Detection of Minimal Residual Disease (MRD) in Multiple Myeloma
  Carlo Martins
  

  #48B Worldwide Interlaboratory Study on Monoclonal Antibody Glycosylation
  Maria Lorna De Leoz
  

  #48C The First Precision Diagnosis of Multiple Myeloma by Use of 21 Tesla FT-ICR Top/Middle-Down de novo Sequencing
  Lidong He
  

  #48C The First Precision Diagnosis of Multiple Myeloma by Use of 21 Tesla FT-ICR Top/Middle-Down de novo Sequencing
  Lidong He
  

Exhibitor Lightning Talks

Tuesday : 17:00-17:30
@ Rooms 2-4 (California Ballroom)

Agilent Technologies (summary)

Cambridge Isotope Labs (summary)

DPX Technologies (summary)

Golden West Diagnostics (summary)

GRENOVA (summary)

Imtakt USA (summary)

Indigo BioAutomation (summary)

IsoSciences (summary)

Jasem (summary)

Kura Biotec (summary)

MRM Proteomics (summary)

Neoteryx (summary)

Phenomenex (summary)

Shimadzu (summary)

SiO2 Medical Products (summary)

Thermo Scientific (summary)

Veritomyx (summary)

Waters (summary)